Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP29068.RA1DkDeN-J0gkwsDffRsPMCkg3prIqNs4aLhONACtjtgA130_assertion description "[Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP29068.RA1DkDeN-J0gkwsDffRsPMCkg3prIqNs4aLhONACtjtgA130_provenance.
• NP11721.RAxvBzrgNU-dx7dFpcThJznrWBBaTo40PrYCGKYcyymP0130_assertion description "[Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP11721.RAxvBzrgNU-dx7dFpcThJznrWBBaTo40PrYCGKYcyymP0130_provenance.
• NP29011.RAKzwqKev4gYaKJCMaah_XR9OayU3xMCdo8urkfG2H4dg130_assertion description "[Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP29011.RAKzwqKev4gYaKJCMaah_XR9OayU3xMCdo8urkfG2H4dg130_provenance.
• NP29023.RAFliAL9Ddrmu_u_YVDN3C8TlQhUYXzm-HyCVppnTNs5E130_assertion description "[Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP29023.RAFliAL9Ddrmu_u_YVDN3C8TlQhUYXzm-HyCVppnTNs5E130_provenance.
• NP576561.RA-WAhPuBJpfgH6UL1QC8e2dpUpZ6_nGEe4-IyiXw7C98130_assertion description "[Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP576561.RA-WAhPuBJpfgH6UL1QC8e2dpUpZ6_nGEe4-IyiXw7C98130_provenance.
• NP436602.RApac8gkDbylqQm1ikZxCwFR7W-sosKdeaFcntTrT4GZU130_assertion description "[Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP436602.RApac8gkDbylqQm1ikZxCwFR7W-sosKdeaFcntTrT4GZU130_provenance.
• NP823342.RAq4TOi7dW_ujsWCzy8SnLIxabZKSUbDNgYM2q9ddzCMw130_assertion description "[Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP823342.RAq4TOi7dW_ujsWCzy8SnLIxabZKSUbDNgYM2q9ddzCMw130_provenance.
• assertion description "[Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP29117.RAT81fw3XdT7HVZE3wqniVfy82dZis6vIhJQo0afN1Zes130_assertion description "[Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP29117.RAT81fw3XdT7HVZE3wqniVfy82dZis6vIhJQo0afN1Zes130_provenance.
• NP29179.RAa4DlXXou2Bj6GKsw6NbdpS7K3tOeed6Nw3cO7l0t-MM130_assertion description "[Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP29179.RAa4DlXXou2Bj6GKsw6NbdpS7K3tOeed6Nw3cO7l0t-MM130_provenance.
• NP312654.RAdmvb13w_Skd3RXB4XcUeaxxmVZCYnfu92Vnfeg_vapo130_assertion description "[Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP312654.RAdmvb13w_Skd3RXB4XcUeaxxmVZCYnfu92Vnfeg_vapo130_provenance.
• NP361416.RAQdKaWfq8MBViXBzTfhi3V1sUGxxhzpGw6_wRrW5gBKA130_assertion description "[Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP361416.RAQdKaWfq8MBViXBzTfhi3V1sUGxxhzpGw6_wRrW5gBKA130_provenance.
• NP71.RA56oTfahhfCxt3oSDaCC0K4QsTUX68sUuNL2leRr4wLE130_assertion description "[Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP71.RA56oTfahhfCxt3oSDaCC0K4QsTUX68sUuNL2leRr4wLE130_provenance.
• NP31540.RAp3p_shMjbEpvvRdP4tSgIDqcM3T8VwOeV91cjemj1WY130_assertion description "[Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP31540.RAp3p_shMjbEpvvRdP4tSgIDqcM3T8VwOeV91cjemj1WY130_provenance.
• NP10268.RAuCUdPNMxGiq9FP-HGNsQ527PYvag60vLFR17nGlK9yM130_assertion description "[Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP10268.RAuCUdPNMxGiq9FP-HGNsQ527PYvag60vLFR17nGlK9yM130_provenance.
• NP29132.RAs63i-0bYOX3PVTHRF_uY00OjxDyBapDTcFTaaee7SIE130_assertion description "[Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP29132.RAs63i-0bYOX3PVTHRF_uY00OjxDyBapDTcFTaaee7SIE130_provenance.
• assertion description "[Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP33016.RAZWaqXT0-iEI5JNaclapDHHin1p1lGH89_OF80G1iS6U130_assertion description "[Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP33016.RAZWaqXT0-iEI5JNaclapDHHin1p1lGH89_OF80G1iS6U130_provenance.
• NP33017.RAUvg6zHwHWGhkkrk5zgKJ-uBkQpSNinjGNPHIsC9Lwr0130_assertion description "[Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP33017.RAUvg6zHwHWGhkkrk5zgKJ-uBkQpSNinjGNPHIsC9Lwr0130_provenance.
• assertion description "[Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP7521.RAThleFb7Yb2-Nb_EvBERUKOaYzQ_VrYOVR1HiI9VvCeY130_assertion description "[Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP7521.RAThleFb7Yb2-Nb_EvBERUKOaYzQ_VrYOVR1HiI9VvCeY130_provenance.
• NP1080724.RAb1Z0YKgBarwN7y_ZqDurMV-oz8pokTsRYE7-kjLpgco130_assertion description "[Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1080724.RAb1Z0YKgBarwN7y_ZqDurMV-oz8pokTsRYE7-kjLpgco130_provenance.
• NP807036.RAnf8zUpGo_tzDZrmmInZRyIbBtfi2cz1tesDlBq0kSeU130_assertion description "[Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP807036.RAnf8zUpGo_tzDZrmmInZRyIbBtfi2cz1tesDlBq0kSeU130_provenance.
• NP33018.RAMAOMiHQxm6GEf45zDWDaVD1Cbqs---B6fhfPvidvK3c130_assertion description "[Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP33018.RAMAOMiHQxm6GEf45zDWDaVD1Cbqs---B6fhfPvidvK3c130_provenance.
• NP33019.RAMWyRF8k6jPSe94plgTahXQBNfTeLBFoT3zXrYjWFuRw130_assertion description "[Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP33019.RAMWyRF8k6jPSe94plgTahXQBNfTeLBFoT3zXrYjWFuRw130_provenance.
• NP33020.RA3G3W41mht-EmU39P2FsUKVYtO5S-uYW8U8ttS52ajQs130_assertion description "[Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP33020.RA3G3W41mht-EmU39P2FsUKVYtO5S-uYW8U8ttS52ajQs130_provenance.
• NP1080722.RA0kFubQYGutjdMHZD2xRmWNfV_TwKhAnX_fMvKM-kDVM130_assertion description "[Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1080722.RA0kFubQYGutjdMHZD2xRmWNfV_TwKhAnX_fMvKM-kDVM130_provenance.
• NP1080723.RA4U2rbQe1-06tu2KXCtX1QfUkU7397i40r14zlBj9ZLE130_assertion description "[Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1080723.RA4U2rbQe1-06tu2KXCtX1QfUkU7397i40r14zlBj9ZLE130_provenance.